Alnylam Pharmaceuticals (ALNY) Reports First Quarter 2014 Financial Results And Highlights Recent Period Activities
5/9/2014 7:23:23 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter 2014, and company highlights.
“The first quarter and recent period have been game changing for Alnylam. Specifically, we believe our alliance with Genzyme strengthens our efforts to bring RNAi therapeutics to patients with rare diseases as potential breakthrough genetic medicines.
Help employers find you! Check out all the jobs and post your resume.
comments powered by